Global CRISPR Editing Platform 麻豆原创 Research Report 2024

Publication ID:

PB503240112

Publication Date:

March 14, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The CRISPR Editing Platform is a proprietary cell engineering process that industrializes CRISPR editing to provide superior cell-based models for your disease research.
The global CRISPR Editing Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CRISPR Editing Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPR Editing Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CRISPR Editing Platform in Gene/Genome Editing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CRISPR Editing Platform include Synthego, Repare Therapeutics, Crisprqc, Horizon, Crown Bioscience, Editas Medicine, Creative Biogene, Mammoth and Synbio Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR Editing Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Editing Platform.
Report Scope
The CRISPR Editing Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR Editing Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR Editing Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Synthego
Repare Therapeutics
Crisprqc
Horizon
Crown Bioscience
Editas Medicine
Creative Biogene
Mammoth
Synbio Technologies
Abace Biology
BRL Medicine Inc
Segment by Type
Animal Cell Editing Platform
Plant Cell Editing Platform
Segment by Application
Gene/Genome Editing
Gene/Genome Screening
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Editing Platform companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global CRISPR Editing Platform 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Animal Cell Editing Platform
1.2.3 Plant Cell Editing Platform
1.3 麻豆原创 by Application
1.3.1 Global CRISPR Editing Platform 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gene/Genome Editing
1.3.3 Gene/Genome Screening
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Editing Platform 麻豆原创 Perspective (2019-2030)
2.2 CRISPR Editing Platform Growth Trends by Region
2.2.1 Global CRISPR Editing Platform 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRISPR Editing Platform Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 CRISPR Editing Platform Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 CRISPR Editing Platform 麻豆原创 Dynamics
2.3.1 CRISPR Editing Platform Industry Trends
2.3.2 CRISPR Editing Platform 麻豆原创 Drivers
2.3.3 CRISPR Editing Platform 麻豆原创 Challenges
2.3.4 CRISPR Editing Platform 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Editing Platform Players by Revenue
3.1.1 Global Top CRISPR Editing Platform Players by Revenue (2019-2024)
3.1.2 Global CRISPR Editing Platform Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global CRISPR Editing Platform 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR Editing Platform Revenue
3.4 Global CRISPR Editing Platform 麻豆原创 Concentration Ratio
3.4.1 Global CRISPR Editing Platform 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Editing Platform Revenue in 2023
3.5 CRISPR Editing Platform Key Players Head office and Area Served
3.6 Key Players CRISPR Editing Platform Product Solution and Service
3.7 Date of Enter into CRISPR Editing Platform 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Editing Platform Breakdown Data by Type
4.1 Global CRISPR Editing Platform Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global CRISPR Editing Platform Forecasted 麻豆原创 Size by Type (2025-2030)
5 CRISPR Editing Platform Breakdown Data by Application
5.1 Global CRISPR Editing Platform Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global CRISPR Editing Platform Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America CRISPR Editing Platform 麻豆原创 Size (2019-2030)
6.2 North America CRISPR Editing Platform 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRISPR Editing Platform 麻豆原创 Size by Country (2019-2024)
6.4 North America CRISPR Editing Platform 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Editing Platform 麻豆原创 Size (2019-2030)
7.2 Europe CRISPR Editing Platform 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRISPR Editing Platform 麻豆原创 Size by Country (2019-2024)
7.4 Europe CRISPR Editing Platform 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Editing Platform 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific CRISPR Editing Platform 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRISPR Editing Platform 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific CRISPR Editing Platform 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Editing Platform 麻豆原创 Size (2019-2030)
9.2 Latin America CRISPR Editing Platform 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRISPR Editing Platform 麻豆原创 Size by Country (2019-2024)
9.4 Latin America CRISPR Editing Platform 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Editing Platform 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa CRISPR Editing Platform 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRISPR Editing Platform 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa CRISPR Editing Platform 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Synthego
11.1.1 Synthego Company Detail
11.1.2 Synthego Business Overview
11.1.3 Synthego CRISPR Editing Platform Introduction
11.1.4 Synthego Revenue in CRISPR Editing Platform Business (2019-2024)
11.1.5 Synthego Recent Development
11.2 Repare Therapeutics
11.2.1 Repare Therapeutics Company Detail
11.2.2 Repare Therapeutics Business Overview
11.2.3 Repare Therapeutics CRISPR Editing Platform Introduction
11.2.4 Repare Therapeutics Revenue in CRISPR Editing Platform Business (2019-2024)
11.2.5 Repare Therapeutics Recent Development
11.3 Crisprqc
11.3.1 Crisprqc Company Detail
11.3.2 Crisprqc Business Overview
11.3.3 Crisprqc CRISPR Editing Platform Introduction
11.3.4 Crisprqc Revenue in CRISPR Editing Platform Business (2019-2024)
11.3.5 Crisprqc Recent Development
11.4 Horizon
11.4.1 Horizon Company Detail
11.4.2 Horizon Business Overview
11.4.3 Horizon CRISPR Editing Platform Introduction
11.4.4 Horizon Revenue in CRISPR Editing Platform Business (2019-2024)
11.4.5 Horizon Recent Development
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Detail
11.5.2 Crown Bioscience Business Overview
11.5.3 Crown Bioscience CRISPR Editing Platform Introduction
11.5.4 Crown Bioscience Revenue in CRISPR Editing Platform Business (2019-2024)
11.5.5 Crown Bioscience Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Detail
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR Editing Platform Introduction
11.6.4 Editas Medicine Revenue in CRISPR Editing Platform Business (2019-2024)
11.6.5 Editas Medicine Recent Development
11.7 Creative Biogene
11.7.1 Creative Biogene Company Detail
11.7.2 Creative Biogene Business Overview
11.7.3 Creative Biogene CRISPR Editing Platform Introduction
11.7.4 Creative Biogene Revenue in CRISPR Editing Platform Business (2019-2024)
11.7.5 Creative Biogene Recent Development
11.8 Mammoth
11.8.1 Mammoth Company Detail
11.8.2 Mammoth Business Overview
11.8.3 Mammoth CRISPR Editing Platform Introduction
11.8.4 Mammoth Revenue in CRISPR Editing Platform Business (2019-2024)
11.8.5 Mammoth Recent Development
11.9 Synbio Technologies
11.9.1 Synbio Technologies Company Detail
11.9.2 Synbio Technologies Business Overview
11.9.3 Synbio Technologies CRISPR Editing Platform Introduction
11.9.4 Synbio Technologies Revenue in CRISPR Editing Platform Business (2019-2024)
11.9.5 Synbio Technologies Recent Development
11.10 Abace Biology
11.10.1 Abace Biology Company Detail
11.10.2 Abace Biology Business Overview
11.10.3 Abace Biology CRISPR Editing Platform Introduction
11.10.4 Abace Biology Revenue in CRISPR Editing Platform Business (2019-2024)
11.10.5 Abace Biology Recent Development
11.11 BRL Medicine Inc
11.11.1 BRL Medicine Inc Company Detail
11.11.2 BRL Medicine Inc Business Overview
11.11.3 BRL Medicine Inc CRISPR Editing Platform Introduction
11.11.4 BRL Medicine Inc Revenue in CRISPR Editing Platform Business (2019-2024)
11.11.5 BRL Medicine Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Synthego
Repare Therapeutics
Crisprqc
Horizon
Crown Bioscience
Editas Medicine
Creative Biogene
Mammoth
Synbio Technologies
Abace Biology
BRL Medicine Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.